XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statement of Changes In Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Receipts on Account of Shares [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Beginning balance at Dec. 31, 2021 $ 15 $ 102,612 $ (6) $ (97,466) $ 5,155
Beginning balance, shares at Dec. 31, 2021 15,452,285          
Loss for the period         (2,220) (2,220)
Other comprehensive income 37 37
Issuance of restricted shares as compensation towards directors [1] 11 9 20
Issuance of restricted shares as compensation towards directors, shares [2] 7,872          
Stock-based compensation 198 198
Stock-based compensation, shares [2] 13,105          
Ending balance at Jun. 30, 2022 $ 15 102,821 9 31 (99,686) 3,190
Ending balance, shares at Jun. 30, 2022 15,473,262          
Beginning balance at Mar. 31, 2022 $ 15 102,763 11 1 (98,559) 4,231
Beginning balance, shares at Mar. 31, 2022 15,452,285          
Loss for the period (1,127) (1,127)
Other comprehensive income 30 30
Issuance of restricted shares as compensation towards directors [1] 11 (2) 9
Issuance of restricted shares as compensation towards directors, shares [2] 7,872          
Stock-based compensation 47 47
Stock-based compensation, shares [2] 13,105          
Ending balance at Jun. 30, 2022 $ 15 102,821 9 31 (99,686) 3,190
Ending balance, shares at Jun. 30, 2022 15,473,262          
Beginning balance at Dec. 31, 2022 $ 15 103,095 4 17 (101,901) 1,230
Beginning balance, shares at Dec. 31, 2022 15,550,730          
Loss for the period (2,462) (2,462)
Other comprehensive income 11 11
Deemed dividend resulted from trigger of down round protection feature of certain warrants granted 855 (855)
Issuance of Ordinary Shares upon completion of public offering, net of offering expenses $ 5 8,725 8,730
Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares [2] 5,376,472          
Issuance of restricted shares as compensation towards directors 9 (4) 5
Issuance of restricted shares as compensation towards directors, shares [2] 14,991          
Stock-based compensation 229 229
Ending balance at Jun. 30, 2023 $ 20 112,913 28 (105,218) 7,743
Ending balance, shares at Jun. 30, 2023 20,892,193          
Beginning balance at Mar. 31, 2023 $ 15 103,156 5 22 (103,187) 11
Beginning balance, shares at Mar. 31, 2023 15,503,632          
Loss for the period (1,176) (1,176)
Other comprehensive income 6 6
Deemed dividend resulted from trigger of down round protection feature of certain warrants granted 855 (855)
Issuance of Ordinary Shares upon completion of public offering, net of offering expenses $ 5 8,725 8,730
Issuance of Ordinary Shares upon completion of public offering, net of offering expenses, shares [2] 5,376,472          
Issuance of restricted shares as compensation towards directors 5 (5)
Issuance of restricted shares as compensation towards directors, shares [2] 12,089          
Stock-based compensation 172 172
Ending balance at Jun. 30, 2023 $ 20 $ 112,913 $ 28 $ (105,218) $ 7,743
Ending balance, shares at Jun. 30, 2023 20,892,193          
[1] Actual issuance occurred subsequent to the balance sheet date.
[2] Represents amount lower than $1.